Prevalence and Prognostic Association of Circulating Troponin in the Acute Respiratory Distress Syndrome

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: Circulating cardiac troponin has been associated with adverse prognosis in the acute respiratory distress syndrome in small and single-center studies; however, comprehensive studies of myocardial injury in acute respiratory distress syndrome using modern high-sensitivity troponin assays, which can detect troponin at much lower circulating concentrations, have not been performed.

DESIGN: We performed a prospective cohort study.

SETTING: We included patients enrolled in previously completed trials of acute respiratory distress syndrome.

PATIENTS: One thousand fifty-seven acute respiratory distress syndrome patients were included.

INTERVENTIONS: To determine the association of circulating high-sensitivity troponin I (Abbott ARCHITECT), with acute respiratory distress syndrome outcomes, we measured high-sensitivity troponin I within 24 hours of intubation. The primary outcome was 60-day mortality.

MEASUREMENTS AND MAIN RESULTS: Detectable high-sensitivity troponin I was present in 94% of patients; 38% of patients had detectable levels below the 99th percentile of a healthy reference population (26 ng/L), whereas 56% of patients had levels above the 99th percentile cut point. After multivariable adjustment, age, cause of acute respiratory distress syndrome, temperature, heart rate, vasopressor use, Sequential Organ Failure Assessment score, creatinine, and PCO2 were associated with higher high-sensitivity troponin I concentration. After adjustment for age, sex, and randomized trial assignment, the hazard ratio for 60-day mortality comparing the fifth to the first quintiles of high-sensitivity troponin I was 1.61 (95% CI, 1.11-2.32; p trend = 0.003). Adjusting for Sequential Organ Failure Assessment score suggested that this association was not independent of disease severity (hazard ratio, 0.95; 95% CI, 0.64-1.39; p = 0.93).

CONCLUSIONS: Circulating troponin is detectable in over 90% of patients with acute respiratory distress syndrome and is associated with degree of critical illness. The magnitude of myocardial injury correlated with mortality.

Original languageEnglish (US)
Pages (from-to)1709-1717
Number of pages9
JournalCritical Care Medicine
Volume45
Issue number10
DOIs
StatePublished - Oct 1 2017

Fingerprint

Troponin
Adult Respiratory Distress Syndrome
Troponin I
Organ Dysfunction Scores
Mortality
Wounds and Injuries
Intubation
Critical Illness
Creatinine
Cohort Studies
Heart Rate
Prospective Studies
Temperature
Population

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

@article{af26a0d32fb548c29eb8cfa77dc3f55a,
title = "Prevalence and Prognostic Association of Circulating Troponin in the Acute Respiratory Distress Syndrome",
abstract = "OBJECTIVE: Circulating cardiac troponin has been associated with adverse prognosis in the acute respiratory distress syndrome in small and single-center studies; however, comprehensive studies of myocardial injury in acute respiratory distress syndrome using modern high-sensitivity troponin assays, which can detect troponin at much lower circulating concentrations, have not been performed.DESIGN: We performed a prospective cohort study.SETTING: We included patients enrolled in previously completed trials of acute respiratory distress syndrome.PATIENTS: One thousand fifty-seven acute respiratory distress syndrome patients were included.INTERVENTIONS: To determine the association of circulating high-sensitivity troponin I (Abbott ARCHITECT), with acute respiratory distress syndrome outcomes, we measured high-sensitivity troponin I within 24 hours of intubation. The primary outcome was 60-day mortality.MEASUREMENTS AND MAIN RESULTS: Detectable high-sensitivity troponin I was present in 94{\%} of patients; 38{\%} of patients had detectable levels below the 99th percentile of a healthy reference population (26 ng/L), whereas 56{\%} of patients had levels above the 99th percentile cut point. After multivariable adjustment, age, cause of acute respiratory distress syndrome, temperature, heart rate, vasopressor use, Sequential Organ Failure Assessment score, creatinine, and PCO2 were associated with higher high-sensitivity troponin I concentration. After adjustment for age, sex, and randomized trial assignment, the hazard ratio for 60-day mortality comparing the fifth to the first quintiles of high-sensitivity troponin I was 1.61 (95{\%} CI, 1.11-2.32; p trend = 0.003). Adjusting for Sequential Organ Failure Assessment score suggested that this association was not independent of disease severity (hazard ratio, 0.95; 95{\%} CI, 0.64-1.39; p = 0.93).CONCLUSIONS: Circulating troponin is detectable in over 90{\%} of patients with acute respiratory distress syndrome and is associated with degree of critical illness. The magnitude of myocardial injury correlated with mortality.",
author = "Thomas Metkus and Eliseo Guallar and Sokoll, {Lori J} and David Morrow and Gordon Tomaselli and Brower, {Roy G} and Schulman, {Steven P} and Frederick Korley",
year = "2017",
month = "10",
day = "1",
doi = "10.1097/CCM.0000000000002641",
language = "English (US)",
volume = "45",
pages = "1709--1717",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Prevalence and Prognostic Association of Circulating Troponin in the Acute Respiratory Distress Syndrome

AU - Metkus, Thomas

AU - Guallar, Eliseo

AU - Sokoll, Lori J

AU - Morrow, David

AU - Tomaselli, Gordon

AU - Brower, Roy G

AU - Schulman, Steven P

AU - Korley, Frederick

PY - 2017/10/1

Y1 - 2017/10/1

N2 - OBJECTIVE: Circulating cardiac troponin has been associated with adverse prognosis in the acute respiratory distress syndrome in small and single-center studies; however, comprehensive studies of myocardial injury in acute respiratory distress syndrome using modern high-sensitivity troponin assays, which can detect troponin at much lower circulating concentrations, have not been performed.DESIGN: We performed a prospective cohort study.SETTING: We included patients enrolled in previously completed trials of acute respiratory distress syndrome.PATIENTS: One thousand fifty-seven acute respiratory distress syndrome patients were included.INTERVENTIONS: To determine the association of circulating high-sensitivity troponin I (Abbott ARCHITECT), with acute respiratory distress syndrome outcomes, we measured high-sensitivity troponin I within 24 hours of intubation. The primary outcome was 60-day mortality.MEASUREMENTS AND MAIN RESULTS: Detectable high-sensitivity troponin I was present in 94% of patients; 38% of patients had detectable levels below the 99th percentile of a healthy reference population (26 ng/L), whereas 56% of patients had levels above the 99th percentile cut point. After multivariable adjustment, age, cause of acute respiratory distress syndrome, temperature, heart rate, vasopressor use, Sequential Organ Failure Assessment score, creatinine, and PCO2 were associated with higher high-sensitivity troponin I concentration. After adjustment for age, sex, and randomized trial assignment, the hazard ratio for 60-day mortality comparing the fifth to the first quintiles of high-sensitivity troponin I was 1.61 (95% CI, 1.11-2.32; p trend = 0.003). Adjusting for Sequential Organ Failure Assessment score suggested that this association was not independent of disease severity (hazard ratio, 0.95; 95% CI, 0.64-1.39; p = 0.93).CONCLUSIONS: Circulating troponin is detectable in over 90% of patients with acute respiratory distress syndrome and is associated with degree of critical illness. The magnitude of myocardial injury correlated with mortality.

AB - OBJECTIVE: Circulating cardiac troponin has been associated with adverse prognosis in the acute respiratory distress syndrome in small and single-center studies; however, comprehensive studies of myocardial injury in acute respiratory distress syndrome using modern high-sensitivity troponin assays, which can detect troponin at much lower circulating concentrations, have not been performed.DESIGN: We performed a prospective cohort study.SETTING: We included patients enrolled in previously completed trials of acute respiratory distress syndrome.PATIENTS: One thousand fifty-seven acute respiratory distress syndrome patients were included.INTERVENTIONS: To determine the association of circulating high-sensitivity troponin I (Abbott ARCHITECT), with acute respiratory distress syndrome outcomes, we measured high-sensitivity troponin I within 24 hours of intubation. The primary outcome was 60-day mortality.MEASUREMENTS AND MAIN RESULTS: Detectable high-sensitivity troponin I was present in 94% of patients; 38% of patients had detectable levels below the 99th percentile of a healthy reference population (26 ng/L), whereas 56% of patients had levels above the 99th percentile cut point. After multivariable adjustment, age, cause of acute respiratory distress syndrome, temperature, heart rate, vasopressor use, Sequential Organ Failure Assessment score, creatinine, and PCO2 were associated with higher high-sensitivity troponin I concentration. After adjustment for age, sex, and randomized trial assignment, the hazard ratio for 60-day mortality comparing the fifth to the first quintiles of high-sensitivity troponin I was 1.61 (95% CI, 1.11-2.32; p trend = 0.003). Adjusting for Sequential Organ Failure Assessment score suggested that this association was not independent of disease severity (hazard ratio, 0.95; 95% CI, 0.64-1.39; p = 0.93).CONCLUSIONS: Circulating troponin is detectable in over 90% of patients with acute respiratory distress syndrome and is associated with degree of critical illness. The magnitude of myocardial injury correlated with mortality.

UR - http://www.scopus.com/inward/record.url?scp=85030441833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030441833&partnerID=8YFLogxK

U2 - 10.1097/CCM.0000000000002641

DO - 10.1097/CCM.0000000000002641

M3 - Article

VL - 45

SP - 1709

EP - 1717

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 10

ER -